2010
DOI: 10.1124/dmd.110.036913
|View full text |Cite
|
Sign up to set email alerts
|

Repeated Injection of High Doses of Hemoglobin-Encapsulated Liposomes (Hemoglobin Vesicles) Induces Accelerated Blood Clearance in a Hemorrhagic Shock Rat Model

Abstract: ABSTRACT:The hemoglobin vesicle (HbV) is an artificial oxygen carrier in which a concentrated hemoglobin solution is encapsulated in a liposome. To apply liposome preparations in clinics, it is important to consider the accelerated blood clearance phenomenon (ABC phenomenon), which involves a loss in the long-circulation half-life after being administered repeatedly to the same animals. The objective of this study was to determine whether the ABC phenomenon is induced by repeated injection of HbV under conditi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7

Relationship

6
1

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 38 publications
2
8
0
Order By: Relevance
“…This is also consistent with the results of Berlin Blue staining portions, which reflect the presence of excessive amounts of hemosiderin, most likely to be from HbV, in the maternal spleen, liver, kidney and placenta but not in the fetal liver. In pregnant rat mothers, a relatively large amount of the 125 I-HbV dose was distributed in the plasma, spleen and liver, which is consistent with a previous report (Taguchi et al, 2009a, b;Taguchi et al, 2011). Since HbV possesses a liposome structure, they are expected to be captured by the MPS (mononuclear phagocyte system) in the spleen and liver (Kiwada et al, 1998).…”
Section: Discussionsupporting
confidence: 87%
“…This is also consistent with the results of Berlin Blue staining portions, which reflect the presence of excessive amounts of hemosiderin, most likely to be from HbV, in the maternal spleen, liver, kidney and placenta but not in the fetal liver. In pregnant rat mothers, a relatively large amount of the 125 I-HbV dose was distributed in the plasma, spleen and liver, which is consistent with a previous report (Taguchi et al, 2009a, b;Taguchi et al, 2011). Since HbV possesses a liposome structure, they are expected to be captured by the MPS (mononuclear phagocyte system) in the spleen and liver (Kiwada et al, 1998).…”
Section: Discussionsupporting
confidence: 87%
“…Forty‐five male SD rats (180–210 g, Kyudou Company, Kumamoto, Japan) were anesthetized and polyethylene catheters (PE 50 tubing, outer diameter equal to 0.965 mm, and an inner diameter equal to 0.58 mm; Becton Dickinson and Company, Tokyo, Japan) containing saline and heparin were then introduced into the left femoral artery. Hemorrhagic shock was induced in 30 rats by removing 40% of the total blood volume according to a previous report . The systemic blood volume was estimated to be 56 mL/kg .…”
Section: Methodsmentioning
confidence: 99%
“…Hemorrhagic shock was induced in 30 rats by removing 40% of the total blood volume according to a previous report. 12,13 The systemic blood volume was estimated to be 56 mL/kg. 14 Under these experimental conditions, the mean arterial pressure remained at less than 40 mm Hg for 30 min.…”
Section: Preparation Of Hemorrhagic Shock Model Rats and Resuscitatiomentioning
confidence: 99%
“…Eighty-eight male Sprague-Dawley rats (180-210 g; Kyudou Co., Kumamoto, Japan) were anesthetized, and polyethylene catheters (PE 50 tubing, outer diameter equal to 0.965 mm and inner diameter equal to 0.58 mm; Becton Dickinson and Co., Tokyo, Japan) containing saline and heparin were then introduced into the left femoral artery. Hemorrhagic shock was induced by removing 40% of the total blood volume according to a previous report (Taguchi et al, 2009(Taguchi et al, , 2011a. Systemic blood volume was estimated to be 56 ml/kg (Sakai et al, 2004).…”
Section: Methodsmentioning
confidence: 99%